Coya Therapeutics, Inc. (COYA) Tops Q3 EPS by 10c

Coya Therapeutics, Inc. (NASDAQ: COYA) reported Q3 EPS of ($0.26), $0.10 better than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Coya Therapeutics, Inc. (COYA) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• ShinyHunters hackers say they stole psychiatric and medical records of DBI staff - Reuters
• Northrop Grumman wins $143M in new U.S. defense contracts